課程名稱 |
在精準醫學時代中的基因檢測面面觀 Genetic Testing in the Era of Precision Medicine |
開課學期 |
109-2 |
授課對象 |
醫學院 醫學系 |
授課教師 |
黃韻如 |
課號 |
Med3069 |
課程識別碼 |
401E38700 |
班次 |
|
學分 |
2.0 |
全/半年 |
半年 |
必/選修 |
選修 |
上課時間 |
星期三9,10(16:30~18:20) |
上課地點 |
基醫503 |
備註 |
本課程以英語授課。與李妮鍾、蔡甫昌、郭柏秀合授 總人數上限:30人 |
|
|
課程簡介影片 |
|
核心能力關聯 |
核心能力與課程規劃關聯圖 |
課程大綱
|
為確保您我的權利,請尊重智慧財產權及不得非法影印
|
課程概述 |
This is a course to introduce the principle of the R&D process of genetic tests in the changing paradigm of precision medicine and the accompanying social and policy implications surrounding genetic testing. |
課程目標 |
After completion of this course, the students will have a comprehensive understanding of genetic testing, genetic counselling, and the policy and social issues related to it. The students will be given opportunities to work in small groups for case studies to reflect real-world scenarios in the development of genetic tests. |
課程要求 |
30% written exam, 40% case study presentation, 30% attendance and in class participation |
預期每週課後學習時數 |
|
Office Hours |
|
指定閱讀 |
|
參考書目 |
待補 |
評量方式 (僅供參考) |
No. |
項目 |
百分比 |
說明 |
1. |
attendance and in-class participation |
30% |
|
2. |
case study presentation |
40% |
|
3. |
written exam |
30% |
|
|
週次 |
日期 |
單元主題 |
Week 1 |
2021/03/03 |
Overview of precision medicine |
Week 2 |
2021/03/10 |
Overview of genetic testing |
Week 3 |
2021/03/17 |
Laboratory Developed Test and Companion Diagnostics: non-cancer |
Week 4 |
2021/03/24 |
Genetic Counseling: non-cancer |
Week 5 |
2021/03/31 |
Laboratory Developed Test and Companion Diagnostics: cancer |
Week 6 |
2021/04/07 |
Genetic Counseling: cancer |
Week 7 |
2021/04/14 |
Case Study: non-cancer |
Week 8 |
2021/04/21 |
Mid-term exam |
Week 9 |
2021/04/28 |
Case Study: cancer |
Week 10 |
2021/05/05 |
Ethics consideration |
Week 11 |
2021/05/12 |
Case Study: Ethics |
Week 12 |
2021/05/19 |
Industry guest lecture (TBA) |
Week 13 |
2021/05/26 |
Regulatory affairs and government policy |
Week 14 |
2021/06/02 |
Reimbursement of genetic tests |
Week 15 |
2021/06/09 |
Case Study: regulatory |
Week 16 |
2021/06/16 |
Impact on the general population and public health |